Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Alectinib hydrochloride
RN: 1256589-74-8
UNII: P9YY73LO6J
InChIKey: GYABBVHSRIHYJR-UHFFFAOYSA-N

Note

  • An anaplastic lymphoma kinase (Alk) inhibitor.

    NCI: An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, alectinib binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors. (NCI Thesaurus)

Molecular Formula

  • C30-H34-N4-O2.CL-H

Molecular Weight

  • 519.0855
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • AF-802 hydrochloride
  • Alectinib hydrochloride

Synonyms

  • AF-802 hydrochloride
  • Alecensa
  • UNII-P9YY73LO6J

Registry Numbers

CAS Registry Number

  • 1256589-74-8

FDA UNII

  • P9YY73LO6J

System Generated Number

  • 1256589748

Structure Descriptors

InChI

1S/C30H34N4O2.ClH/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29;/h5-6,15-17,21,32H,4,7-14H2,1-3H3;1H

InChIKey

GYABBVHSRIHYJR-UHFFFAOYSA-N

Smiles

Cl.CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6